San Antonio—Emtora Biosciences, a San Antonio biotech startup formerly known as Rapamycin Holdings, is planning to test its drug, eRapa, as a ...
News
- Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding
- Amgen: 1Q Earnings Snapshot
The world's largest biotech drugmaker posted revenue of $5.56 billion in the period, which matched Street forecasts. Amgen expects full-year earnings ...
- Form DEF 14A Fortress Biotech, Inc. For: Jun 18
Form DEF 14A Fortress Biotech, Inc. For: Jun 18 .... The Annual Meeting of Stockholders of Fortress Biotech, Inc. will be held at the offices of ..... Professor of Medicine at the University of Texas Health Science Center at San Antonio.
- Higher education notebook
Prior to UALR, he was vice president for business affairs at Texas A&M University-San Antonio, vice chancellor for finance and administration at the ... director of the Arkansas Biosciences Institute to the positions permanently, the ...
- Texas Biomed to start 5 year study on HIV vaccine
SAN ANTONIO — SAN ANTONIO---Some very exciting news coming out of Texas Biomedical Research Institute today where a pre-clinical AIDS ...